Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 6/2008

Open Access 01-06-2008 | Correspondence

Comment on “Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008” by Dellinger et al.

Authors: A. M. E. Spoelstra - de Man, A. R. J. Girbes

Published in: Intensive Care Medicine | Issue 6/2008

Login to get access

Excerpt

Sir: We read with interest the recent revision of the Surviving Sepsis Campaign (SSC) guidelines by Dellinger et al. [1]. The use of the GRADE system to classify the strength of the recommendations has certainly improved the guidelines. However, we regret that not all guidelines were adjusted according to the current literature. …
Literature
1.
Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL (2008) Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34:17–60PubMedCrossRef
2.
Liberati A, D'Amico R, Pifferi, Torri V, Brazzi L (2004) Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database Syst Rev CD000022
3.
Hammond JM, Potgieter PD (1995) Long-term effects of selective decontamination on antimicrobial resistance. Crit Care Med 23:637–645PubMedCrossRef
4.
van der Voort PH, van Roon EN, Kampinga GA, Boerma EC, Gerritsen RT, Egbers PH, Kuiper MA (2004) A before–after study of multi-resistance and cost of selective decontamination of the digestive tract. Infection 32:271–277PubMedCrossRef
5.
de la Cal MA, Cerda E, van Saene HK, Garcia-Hierro P, Negro E, Parra ML, Arias S, Ballesteros D (2004) Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit. J Hosp Infect 56:175–183PubMedCrossRef
6.
Abraham E, Laterre PF, Garg R, Levy H, Talwar D, Trzaskoma BL, Francois B, Guy JS, Bruckmann M, Rea-Neto A, Rossaint R, Perrotin D, Sablotzki A, Arkins N, Utterback BG, Macias WL (2005) Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 353:1332–1341PubMedCrossRef
7.
Stoutenbeek CP, van Saene HK, Zandstra DF (1987) The effect of oral non-absorbable antibiotics on the emergence of resistant bacteria in patients in an intensive care unit. J Antimicrob Chemother 19:513–520PubMedCrossRef
8.
Lingnau W, Berger J, Javorsky F, Fille M, Allerberger F, Benzer H (1998) Changing bacterial ecology during a five-year period of selective intestinal decontamination. J Hosp Infect 39:195–206PubMedCrossRef
9.
Leone M, Albanese J, Antonini F, Nguyen-Michel A, Martin C (2003) Long-term (6-year) effect of selective digestive decontamination on antimicrobial resistance in intensive care, multiple-trauma patients. Crit Care Med 31:2090–2095PubMedCrossRef
10.
Sarginson RE, Taylor N, Reilly N, Baines PB, van Saene HK (2004) Infection in prolonged pediatric critical illness: a prospective four-year study based on knowledge of the carrier state. Crit Care Med 32:839–847PubMedCrossRef
11.
Viviani M, van Saene HK, Dezzoni R, Silvestri L, Di Lenarda R, Berlot G, Gullo A (2005) Control of imported and acquired methicillin-resistant Staphylococcus aureus (MRSA) in mechanically ventilated patients: a dose-response study of enteral vancomycin to reduce absolute carriage and infection. Anaesth Intensive Care 33:361–372PubMed
12.
Bonten MJ, Kluytmans J, de Smet AM, Bootsma M, Hoes A (2003) Selective decontamination of digestive tract in intensive care. Lancet 362:2118–2119PubMedCrossRef
13.
Brun-Buisson C, Legrand P, Rauss A, Richard C, Montravers F, Besbes M, Meakins JL, Soussy CJ, Lemaire F (1989) Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. Ann Intern Med 110:873–881PubMed
14.
de Jonge E, Schultz MJ, Spanjaard L, Bossuyt PM, Vroom MB, Dankert J, Kesecioglu J (2003) Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 362:1011–1016PubMedCrossRef
15.
Silvestri L, van Saene HK, Milanese M, Fontana F, Gregori D, Oblach L, Piacente N, Blazic M (2004) Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial. Eur Respir J 23:921–926PubMedCrossRef
16.
Bergmans DC, Bonten MJ, Gaillard CA, Paling JC, van der GS, van Tiel FH, Beysens AJ, de Leeuw PW, Stobberingh EE (2001) Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med 164:382–388PubMed
17.
Korinek AM, Laisne MJ, Nicolas MH, Raskine L, Deroin V, Sanson-Lepors MJ (1993) Selective decontamination of the digestive tract in neurosurgical intensive care unit patients: a double-blind, randomized, placebo-controlled study. Crit Care Med 21:1466–1473PubMedCrossRef
18.
Pugin J, Auckenthaler R, Lew DP, Suter PM (1991) Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. A randomized, placebo-controlled, double-blind clinical trial. JAMA 265:2704–2710PubMedCrossRef
19.
Schardey HM, Joosten U, Finke U, Staubach KH, Schauer R, Heiss A, Kooistra A, Rau HG, Nibler R, Ludeling S, Unertl K, Ruckdeschel G, Exner H, Schildberg FW (1997) The prevention of anastomotic leakage after total gastrectomy with local decontamination. A prospective, randomized, double-blind, placebo-controlled multicenter trial. Ann Surg 225:172–180PubMedCrossRef
20.
Basso N, Bagarani M, Materia A, Fiorani S, Lunardi P, Speranza V (1981) Cimetidine and antacid prophylaxis of acute upper gastrointestinal bleeding in high risk patients. Controlled, randomized trial. Am J Surg 141:339–341PubMedCrossRef
21.
Bresalier RS, Grendell JH, Cello JP, Meyer AA (1987) Sucralfate suspension versus titrated antacid for the prevention of acute stress-related gastrointestinal hemorrhage in critically ill patients. Am J Med 83:110–116PubMedCrossRef
22.
Poleski MH, Spanier AH (1986) Cimetidine versus antacids in the prevention of stress erosions in critically ill patients. Am J Gastroenterol 81:107–111PubMed
23.
Stothert JC Jr, Simonowitz DA, Dellinger EP, Farley M, Edwards WA, Blair AD, Cutler R, Carrico CJ (1980) Randomized prospective evaluation of cimetidine and antacid control of gastric pH in the critically ill. Ann Surg 192:169–174PubMedCrossRef
24.
Cook DJ, Witt LG, Cook RJ, Guyatt GH (1991) Stress ulcer prophylaxis in the critically ill: a meta-analysis. Am J Med 91:519–527PubMedCrossRef
25.
Cook D, Guyatt G, Marshall J, Leasa D, Fuller H, Hall R, Peters S, Rutledge F, Griffith L, McLellan A, Wood G, Kirby A (1998) A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med 338:791–797PubMedCrossRef
26.
Messori A, Trippoli S, Vaiani M, Gorini M, Corrado A (2000) Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials. BMJ 321:1103–1106PubMedCrossRef
27.
Zandstra DF, Stoutenbeek CP (1994) The virtual absence of stress-ulceration related bleeding in ICU patients receiving prolonged mechanical ventilation without any prophylaxis. A prospective cohort study. Intensive Care Med 20:335–340PubMedCrossRef
28.
Maury E, Tankovic J, Ebel A, Offenstadt G (2005) An observational study of upper gastrointestinal bleeding in intensive care units: is Helicobacter pylori the culprit? Crit Care Med 33:1513–1518PubMedCrossRef
29.
Kahn JM, Doctor JN, Rubenfeld GD (2006) Stress ulcer prophylaxis in mechanically ventilated patients: integrating evidence and judgment using a decision analysis. Intensive Care Med 32:1151–1158PubMedCrossRef
30.
Ben Menachem T, Fogel R, Patel RV, Touchette M, Zarowitz BJ, Hadzijahic N, Divine G, Verter J, Bresalier RS (1994) Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. A randomized, controlled, single-blind study. Ann Intern Med 121:568–575PubMed
31.
Misra UK, Kalita J, Pandey S, Mandal SK, Srivastava M (2005) A randomized placebo controlled trial of ranitidine versus sucralfate in patients with spontaneous intracerebral hemorrhage for prevention of gastric hemorrhage. J Neurol Sci 239:5–10PubMedCrossRef
32.
Reusser P, Gyr K, Scheidegger D, Buchmann B, Buser M, Zimmerli W (1990) Prospective endoscopic study of stress erosions and ulcers in critically ill neurosurgical patients: current incidence and effect of acid-reducing prophylaxis. Crit Care Med 18:270–274PubMedCrossRef
33.
Kantorova I, Svoboda P, Scheer P, Doubek J, Rehorkova D, Bosakova H, Ochmann J (2004) Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepatogastroenterology 51:757–761PubMed
34.
Preiser JC (2007) Intensive glycemic control in med-surg patients (European Glucontrol trial). Program and abstracts of the Society of Critical Care Medicine 36th Critical Care Congress February 17–21 Orlando, Florida
35.
Brunkhorst FM, Kuhnt E, Engel C, Meier-Hellman A, Ragaller M, Quintel M, Weiler N, Grundling M, Oppert M, Deufel T, et al. (2005) Intensive insulin therapy in patients with severe sepsis and septic shock is associated with increased rate of hypoglycemia – results from a randomized multicenter study (VISEP). Infection 33:19–20
36.
Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354:449–461PubMedCrossRef
Metadata
Title
Comment on “Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008” by Dellinger et al.
Authors
A. M. E. Spoelstra - de Man
A. R. J. Girbes
Publication date
01-06-2008
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 6/2008
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-008-1089-5

Other articles of this Issue 6/2008

Intensive Care Medicine 6/2008 Go to the issue

Experimental

The effect of hypoxemic resuscitationfrom hemorrhagic shock on blood pressure restoration and on oxidative and inflammatory responses

Êditorial

On the way towards eradication of catheter-related infections!

Correspondence

Comment on “Case involving end-of-life decision issues in Italy” by Bock et al.

Brief Report

Pharmacokinetics of meropenem during intermittent and continuous intravenous application in patients treated by continuous renal replacement therapy

Correspondence

Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

Editorial

Back to basics in septic shock